Application of the QbD-based approach in the early development of liposomes for nasal administration.

Pallagi, Edina; Jójárt-Laczkovich, Orsolya; Németh, Zsófia; Szabó-Révész, Piroska; Csóka, Ildikó

Pallagi, Edina; Jójárt-Laczkovich, Orsolya; Németh, Zsófia; Szabó-Révész, Piroska; Csóka, Ildikó.

Afiliación

Pallagi E; University of Szeged, Faculty of Pharmacy, Institute of Pharmaceutical Technology and Regulatory Affairs, H-6720 Szeged, Eötvös u. 6, Hungary. Electronic address: edina.pallagi@pharm.u-szeged.hu.
Jójárt-Laczkovich O; University of Szeged, Faculty of Pharmacy, Institute of Pharmaceutical Technology and Regulatory Affairs, H-6720 Szeged, Eötvös u. 6, Hungary.
Németh Z; University of Szeged, Faculty of Pharmacy, Institute of Pharmaceutical Technology and Regulatory Affairs, H-6720 Szeged, Eötvös u. 6, Hungary.
Szabó-Révész P; University of Szeged, Faculty of Pharmacy, Institute of Pharmaceutical Technology and Regulatory Affairs, H-6720 Szeged, Eötvös u. 6, Hungary.
Csóka I; University of Szeged, Faculty of Pharmacy, Institute of Pharmaceutical Technology and Regulatory Affairs, H-6720 Szeged, Eötvös u. 6, Hungary.

Int J Pharm ; 562: 11-22, 2019 May 01.

Article en En | MEDLINE | ID: mdl-30877028

Asunto(s)

Diseño de Fármacos; Liposomas; Administración Intranasal; Encéfalo/metabolismo

Palabras clave

Lipophilic drug containing liposome; Liposome; Nanocarriers; Nasal administration; Quality by Design; Risk assessment; Risk-based formulation

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Diseño de Fármacos / Liposomas Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Int J Pharm Año: 2019 Tipo del documento: Article Pais de publicación: Países Bajos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google